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The Hispanic health paradox (HHP) is an epidemiological paradox that describes the 
observation that the Hispanic population in the United States tends to have better health 
outcomes than would be expected, given the socioeconomic profile of this population. As a clear 
correlation between socioeconomic status (SES) and health outcomes has been established, one 
would expect the Hispanic population to have relatively poorer outcomes than the non-Hispanic 
(NH) white population and comparable outcomes to the NH black population. Among other 
health outcomes, the HHP has been observed with respect to cardiovascular disease (CVD), as 
analyses by the American Heart Association and Centers for Disease Control have shown that 
the Hispanic population has a lower prevalence of CVD than the NH white and NH black 
populations. However, some smaller studies challenge the existence of the HHP. Additionally, 
the impact of CVD risk factors (such as diabetes) and level of acculturation to the United States 
on the HHP is understudied. By utilizing data from the 2018 National Health Interview Survey, 
this thesis will support the existing literature that shows that the HHP is found with respect to 
CVD. I will also argue that the HHP with respect to CVD is present among populations with 
diabetes but to a lesser extent than within the general population. This suggests that the 
prevalence of CVD among Hispanic individuals in the general population may be artificially low 
due to lack of health care utilization. Finally, I will argue that the HHP is present among both 
U.S.-born and foreign-born populations, indicating that the high proportion of immigrants in the 
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CHAPTER I: INTRODUCTION 
 
Introduction to the Hispanic Health Paradox 
The Hispanic health paradox (HHP) refers to the “relatively good health of Latinos 
within the U.S., despite what lower levels of socioeconomic status might predict” (Camacho-
Rivera et al., 2015). For example, the Hispanic population has been shown to have a longer life 
expectancy and lower rates of cancer than the non-Hispanic (NH) white population, as well as 
comparable infant mortality rates and rates of low-birth-weight infants to the NH white 
population (Kochanek et al., 2019; Siegel et al., 2015; Kaiser Family Foundation, 2017; 
Acevedo-Garcia et al., 2007). This is paradoxical given that the Hispanic population is, on 
average, less educated and less wealthy than the NH white population (Fontenot et al., 2018) (US 
Census Bureau, 2017). A clear relationship between socioeconomic status (SES) and health has 
been established, by which lower SES confers worse health outcomes (Adler et al., 1994). Given 
this gradient, one would expect the Hispanic population to have worse health outcomes than the 
NH white population, not similar (or better) health outcomes. The paradox likely does not apply 
indiscriminately to all Hispanic individuals, but instead varies depending on a variety of factors 
such as region of birth, gender, level of acculturation and socioeconomic status. 
The HHP has also been observed when studying cardiovascular disease (CVD), although 
these studies are somewhat controversial. National surveys utilized by the American Heart 
Association and Centers for Disease Control show that the Hispanic population has a lower 
prevalence of CVD than the NH white and NH black populations. However, some smaller 
studies have shown that Hispanic individuals have a similar, if not higher prevalence of CVD 
compared to NH white individuals. (Hunt et al., 2002; Pandey et al., 2001) There are several 
possible explanations that could account for this difference, one being that two of the small-scale 
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studies referenced examined Mexican-Americans instead of the Hispanic population in general. 
(Hunt et al., 2002; Pandey et al., 2001) More information regarding the HHP with respect to 
CVD is needed in order to determine if the paradox is a true phenomenon or the result of under-
reporting and ambiguous disease classifications. 
The purpose of this thesis is two-fold: one, to add to the existing research that shows that the 
Hispanic population has an unexpectedly low prevalence of CVD in the United States; and two, 
to answer the following two research questions: 
1) Is the HHP (with respect to CVD) present among populations with diabetes, a CVD risk 
factor?  
2) Is the HHP (with respect to CVD) present when region of birth is taken into account?  
 
Brief Overview of the Hispanic Population  
The Hispanic population is the largest racial or ethnic minority population in the United 
States. As of July 2018, there were 59.9 million Hispanics in the U.S., constituting 18.3% of the 
nation’s population (Frances Alonzo, 2019). Ten states contain a population of 1 million or more 
Hispanic residents: Arizona, California, Colorado, Florida, Georgia, Illinois, New Jersey, New 
Mexico, New York and Texas (Frances Alonzo, 2019). The Hispanic population in the U.S. 
includes both U.S.-born Hispanics as well as foreign-born individuals who immigrated from 
Latin American, the Caribbean, or Spain (Velasco-Mondragon et al., 2016).  
The Hispanic health paradox (the motivating phenomenon behind this thesis) centers 
around the concept of socioeconomic status. In light of this, I will provide information regarding 
income and education levels within the Hispanic population. I will provide the same information 
with regards to the NH black and NH white populations as well. I will do this in order to show 
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that the Hispanic population is socioeconomically comparable to the NH black population but 
lower than the NH white population.  
The Hispanic population is similar to the NH black population in terms of income level, 
but far below that of the NH white population. In 2017, the real median income for Hispanic 
households was $50,486, while that of black households was $40,258 (data regarding the NH 
black population unavailable) (Fontenot et al., 2018). The NH white household real median 
income was nearly 25% greater than that of Hispanics at $68,145 (Fontenot et al., 2018).  Also in 
2017, 18.3% of the Hispanic population (representing 10.8 million people) in the U.S. lived 
below the federal poverty level (FPL), comparable to 21.2% of the black population (Fontenot et 
al., 2018).  Conversely, only 8.7% of the NH white population lived below the FPL (Figure 1) 
(Fontenot et al., 2018).   




In 2017, the percentage of Hispanic individuals aged 25 or older who had graduated from 




















Bureau, 2017). The percentage of Hispanic individuals who had graduated from high school was 
also less than the black population (87%) by a fairly wide margin. Only 17% of the Hispanic 
population and 24% of the black population aged 25 or older had completed a bachelor’s degree 
or higher level of education. Meanwhile, 38% of NH white population above 25 years old had 
reached this level of education—over twice as many as the Hispanic population in terms of 
percentage (Figure 2). (US Census Bureau, 2017). 
Figure 2: Educational Attainment by Race/Ethnicity, 2017 (US Census Bureau, 2017)  
 
 
Outline of This Thesis 
The second chapter of this thesis will provide a review of the literature regarding the 
Hispanic health paradox. I will identify the various fields in which the HHP has been observed, 
as well as give an overview of the proposed explanations for the HHP. I will end by pointing out 
the gaps in the existing literature that motivated my data analysis.  
The third and fourth chapters of this thesis will consist of a data analysis and discussion. I 
will utilize data from the National Health Interview Survey (NHIS), a survey conducted annually 
across thousands of households throughout the country. I will use this data to show that the 


















Completed High School Bachelor's Degree
Hispanics NH Whites Blacks
 9 
NH white and NH black populations. I will also show that the prevalence of CVD within the 
Hispanic population with diabetes is lower than within the NH white and NH black populations, 
arguing that the HHP is still present among populations with diabetes. However, I will show that 
the differences between the prevalence of CVD in the Hispanic population and NH white and 
NH black populations with diabetes are smaller than within the general population, suggesting 
that the presence of the HHP with respect to CVD in the general population may be exaggerated 
due to low rates of health care utilization. Finally, I will show that the prevalence of CVD within 
the foreign-born Hispanic population is lower than within the foreign-born NH white population. 
Thus, I will argue that the HHP is still present within the foreign-born population, as it is in the 
U.S.-born population, suggesting that the high proportion of immigrants in the Hispanic 
population is not enough to account for the paradox. I will conclude with a summation of the 
literature review, data analysis and discussion.  
 
A Note on Terminology 
The term “Hispanic” refers to people who speak Spanish and/or are descended from 
Spanish-speaking populations, whereas Latino refers to people who are from and/or descended 
from people from Latin America (Cole, 2019). Both terms are used in the literature. In this 
thesis, the term “Hispanic” will be used unless the study in question specifically examined Latin 
Americans. Additionally, Mexican immigrants comprise 64% of all Hispanic immigrants in the 
United States (Smith‐Miller et al., 2017). Thus, studies which focus on Mexican immigrants 
exclusively will be included in this discussion, as this population makes up the majority of 
Hispanic immigrants. To avoid confusion or false conclusions, the population studied (Hispanic, 
Latin American or Mexican immigrants) will be specified as it is discussed.  
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CHAPTER II: LITERATURE REVIEW 
Outline of Literature Review  
The Hispanic health paradox (known as the Latino health paradox, or simply the 
Hispanic/Latino paradox) has been described as an epidemiological phenomenon (Markides & 
Coreil, 1986; Ruiz et al., 2016). Generally, the term refers to the trend that the Hispanic 
population in the United States has better health outcomes than expected relative to other 
racial/ethnic groups. The terminology used may vary based on the specific condition being 
discussed; for example, the observance of the HHP with respect to life expectancy is often called 
the “Hispanic mortality paradox” (Ruiz et al., 2016). This literature review will provide an 
explanation of the socioeconomic status-health gradient, how it demonstrates the paradoxical 
nature of Hispanic health outcomes with respect to a number of conditions, and then provide an 
overview of the discussion of the HHP with respect to cardiovascular disease.  
 
The Socioeconomic Status (SES)-Health Gradient  
It has been well-established that there is a correlation between SES and health.(Adler et 
al., 1994) SES is usually described as some combination of income level, education level and 
occupation, which typically serve as means of measuring economic status, social status, and 
work status, respectively (Adler et al., 1994). Differences in SES are linked with rates of 
mortality and morbidity for nearly every disease and condition (Adler et al., 1994). Multiple 
studies have shown that individuals who are classified as having a low SES experience worse 
health outcomes than individuals classified as having a high SES, with a step-by-step gradient in 
between (Adler et al., 1994). This gradient is known as the SES-health gradient.  
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The most famous study documenting the SES-health gradient is the Whitehall study, 
conducted by M.G. Marmot and colleagues. This study covered 17,350 British civil servants 
over a ten-year period. These civil servants were classified according to employment grade by 
the researchers. The following classifications were made, from lowest status to highest status: the 
“others,” consisting primarily of unskilled manual workers; the clerical workers; the 
professional/executive workers; and the administrative officials. Marmot et al. found that for 
nearly every major cause of death, the lower two grades (the “others” and clerical workers) had a 
higher mortality risk than the two higher grades (professionals/executives and administrators). 
This list includes but is not limited to coronary heart disease (which accounted for 43% of all 
deaths), lung cancer, chronic bronchitis, accidents and violence, and suicide. Marmot et al. also 
controlled for smoking, a major health behavior, and found that differences in smoking behavior 
did not fully account for the differences in deaths from respiratory diseases. Perhaps most 
shocking, there was a three-fold difference in relative risk of mortality between the lowest grade 
group and the highest grade group (Marmot et al., 1984). 
A composite of several studies that examined mortality rates of at least four levels of SES 
shows a nearly-linear relationship between SES and mortality. Annual death rates and infant 
mortality rates are highest in the lowest SES populations and then decrease in a stepwise fashion 
with rising SES and are lowest within the high SES populations (Adler et al., 1994). Thus, it is 
clear that differences in health outcomes occur at every level of SES.  
Figure 1: Figure pulled from Adler et al. Shows that across four separate studies, annual death 
rate and infant mortality increase as SES decreases. This figure demonstrates the step-wise 





The HHP and Immigration Status 
An additional element of the HHP is the role that immigration status plays in the lives of 
many Hispanic individuals. A large proportion (34%) of the Hispanic population in the U.S. is 
composed of immigrants (Flores, 2017). Castañeda and colleagues argue that in order to achieve 
a substantive change in health outcomes, “immigration must be treated as a health determinant 
itself” (2015). As Castañeda et al. point out, much of the research that seeks to explain the HHP 
focuses on individual behavioral choices, while ignoring the broader social and economic 
contexts influencing these choices. Many studies also focus on specific cultural practices, which 
unfortunately can lead to “superficial or stereotyped notions of culture” (Castañeda, 2015). For 
example, researchers may simplify “notions of gender, family relations and cultural values such 
as…‘machismo’” (Castañeda, 2015). These over-simplifications not only ignore the diversity 
within the Hispanic population, but also ignore structural factors that impact immigrant health. 
Castañeda et al. list “poor access to transportation, elevated health care costs, changing access to 
healthy foods, [and] differences in labor practices” as structural factors that disproportionately 
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affect immigrants (2015). Thus, it is clear that when seeking to understand the HHP, cultural 
factors alone are insufficient. Immigration status has profound impacts on the economic and 
social context in which many Hispanic individuals operate, and thus must be studied as a social 
determinant of health.  
 
The HHP and Life Expectancy  
The clearest way to see the Hispanic health paradox is to look at life expectancy. In the 
United States, individuals of Hispanic origin live longer than non-Hispanic individuals. This 
particular aspect of the HHP is often referred to as the Hispanic mortality paradox (or advantage) 
(Ruiz et al., 2016). It was first documented in 1983 by K.S. Markides and colleagues and has 
persisted to this day (Markides, 1983). For example, in 2017, Hispanic individuals had a life 
expectancy advantage at birth of 3.3 years over NH white individuals and 6.9 years over NH 
black individuals (Kochanek et al., 2019). The life expectancy at birth for the Hispanic 
population was 81.8 years (79.1 years for males and 84.3 years for females), which significantly 
exceeded 78.5 years (76.1 years for males, 81.0 years for females) for the NH white population 
and 74.9 years (71.5 years for males, 78.1 years for females) for the NH black population 
(Kochanek et al., 2019). The Centers for Disease Control (CDC) has documented this trend of 
the Hispanic population living longer since 2006; unfortunately, the CDC did not report life 
expectancy information by Hispanic ethnicity prior to this time (CDC, 2018). However, earlier 
researchers were able to use creative methods to approximate the life expectancy of the Hispanic 
population in the U.S. For example, Markides et al. utilized a study in which researchers 
analyzed the mortality rates among persons in Texas with Spanish surnames (Markides, 1983).   






Methodological Explanations for the HHP, based on the Hispanic Mortality Paradox 
 Two primary hypotheses have been proposed to explain the Hispanic mortality paradox 
as a function of data bias, meaning that the HHP is only observed because of a lack of a 
comprehensive review of the entire Hispanic population and not because Hispanic individuals 
have a health advantage (Abraído-Lanza, 1999). Presumably, these hypotheses can be extended 
to the HHP. The first hypothesis, the salmon bias hypothesis, proposes that Hispanic mortality in 
the United States is artificially low because a large portion of the Hispanic population are 
immigrants, and many of these immigrants choose to return to their country of origin before 
passing away. Abraído-Lanza et al. tested the salmon bias hypothesis by examining the mortality 
rate amongst Hispanic populations that had a high likelihood of dying in the United States 
(1999). They examined Cubans residing in the U.S., because at the time of this study (1999) 
Cubans could not easily return to their home country. They also looked at Puerto Ricans, as even 
if these individuals chose to return to their homeland, their mortality would still be counted in the 
overall U.S. morality rate. Finally, they also assumed that U.S.-born Hispanic individuals would 




























Life Expectancy from Birth, 2017
Both sexes Male Female
 15 
was based off the concept of familism, which describes “the importance of family regarding 
support, comfort and services” in Hispanic culture (Hernández & Bámaca-Colbert, 2016). The 
results showed that Puerto Ricans and Cubans have lower mortality than NH whites, and U.S.-
born Hispanics have lower overall mortality than U.S.-born whites. Thus, when specifically 
examining Hispanic individuals likely to die in the U.S., the researchers found that these 
individuals still have a lower mortality rate than U.S.-born NH white individuals. This 
undermines the hypothesis that the death rate amongst Hispanics in the U.S. is artificially low 
because Hispanics choose to return to their county-of-origin before passing away, as these three 
groups were chosen because they were likely to die in the U.S. Given that these three groups 
were likely to die in the U.S. yet still have paradoxically low mortality rates, this study does not 
support the salmon bias hypothesis and instead suggests that the Hispanic mortality paradox is a 
true phenomenon (Abraído-Lanza et al., 1999).  
 The second hypothesis that attempts to explain the Hispanic mortality paradox is the 
healthy migrant hypothesis. This hypothesis proposes that the “healthy migrant effect,” meaning 
the fact that immigrants are typically healthier than the general population, is responsible for the 
low Hispanic mortality rate, as a large proportion (about 34%) of the Hispanic population is 
composed of immigrants (Flores, 2017). Abraído-Lanza et al. tested this hypothesis by 
examining the mortality rates amongst both foreign-born Hispanic and NH white individuals. If 
this hypothesis were true, then there would be no difference between foreign-born Hispanic and 
foreign-born NH white individuals, as all immigrants are subject to selection factors (1999). 
However, Abraído-Lanza et al. found that foreign-born Hispanics do, in fact, have lower 
mortality than their foreign-born white counterparts (1999). In the 45-64 age group, foreign-born 
Hispanic individuals were about half as likely to die than foreign-born NH white individuals in 
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the time period studied, while in the 65+ age group foreign-born Hispanic individuals were less 
than half as likely to die than their NH white counterparts (Abraído-Lanza et al., 1999). This 
indicates that even amongst immigrants, Hispanics have a health advantage. This suggests that 
the large proportion of immigrants within the Hispanic population alone does not account for the 
Hispanic mortality advantage. While not refuting the healthy migrant hypothesis, this study 
suggests that this hypothesis alone is not sufficient to account for the HHP.  Thus, neither the 
salmon bias hypothesis nor the healthy migrant hypothesis can adequately account for the 
Hispanic mortality advantage.  
 
The HHP and Other Health Outcomes 
Psychiatric Illness: A study published by Marvin Karno and Robert Edgerton in 1969 regarding 
mental illness amongst Mexican-Americans was one of the first studies remarking on the HHP. 
Karno and Edgerton observed that Mexican-Americans in California under-utilized psychiatric 
facilities. For example, Mexican-Americans accounted for only 3.3% of the resident population 
of “California’s state hospitals for the mentally ill,” whereas Karno and Edgerton expected this 
number to be closer to 9-10% (Karno & Edgerton, 1969). Karno and Edgerton described this 
finding—and other similar findings—as an “epidemiological paradox” (Karno & Edgerton, 
1969).  
 
Cancer: Although cancer is the number one cause of death in the Hispanic population in the 
United States, the lifetime probability of developing cancer among Hispanic men and women is 
less than among NH white men and women. The lifetime probability of developing cancer 
among Hispanic men and women is 39% and 34%, respectively, while the lifetime probability of 
developing cancer among NH white men and women is 42% and 39%, respectively (Siegel et al., 
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2015). Additionally, Hispanic individuals are less likely than NH white individuals to be 
diagnosed with prostate, breast, lung and bronchus and colorectum cancers, the four most 
common cancers (Siegel et al., 2015). Thus, the HHP is present when studying cancer.  
 
Birth outcomes: The HHP has also been observed when studying birth outcomes in the United 
States. Hispanic infants are found to have a similar low-birth-weight (LBW) rate compared to 
white infants, although the SES-health gradient would predict that Hispanic women would have 
a higher LBW rate (Fuentes-Afflick & Lurie, 1997). A 1997 study conducted by Fuentes-Afflick 
and Lurie found that the LBW rate among Hispanic infants (referred to as “Latino” in the study) 
was 6.2%, comparable to the LBW rate of 5.8% among white infants. It is worth noting that a 
later study, conducted in 2007, distinguished between the LBW rates of foreign-born and U.S.-
born Hispanic populations. Acevedo-Garcia et al. found that foreign-born Hispanic women were 
less likely to have LBW infants than U.S.-born Hispanic women (2007). This supports the 
healthy migrant hypothesis, as the protective effect against LBW seems to be much more present 
amongst immigrant Hispanic women compared to U.S.-born Hispanic women.  
 
Infant Mortality: The Hispanic population in the U.S. has a similar infant mortality rate to the 
NH white population in the U.S. Similarly to the discussion regarding low birth weight, this is 
paradoxical given that the socioeconomic profile of the Hispanic population would predict a 
higher infant mortality rate than the NH white population. In 2017, the infant mortality rate 
within the Hispanic population was 5.1 infants per 1,000 live births (Kaiser Family Foundation, 
2017). Similarly, the infant mortality rate within the NH white population was 4.7 infants per 
1,000 live births. The NH black population had an infant mortality rate about twice that of the 
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Hispanic and NH white populations: 10.9 infants per 1,000 live births (Kaiser Family 
Foundation, 2017). Given that the NH black and Hispanic populations have similar 
socioeconomic profiles, one would expect that the Hispanic infant mortality rate would be closer 
to that of the NH black population rather than the NH white population. Again, this observation, 
that the Hispanic population has an unexpectedly low infant mortality rate, is part of the 
epidemiological phenomenon known as the HHP.   
 
The HHP and Cardiovascular Disease (CVD) 
Ambiguity around the term “CVD” 
Cardiovascular disease (CVD) is the number one cause of death globally (WHO, 2017). 
The World Health Organization (WHO) defines CVD as “a group of disorders of the heart and 
blood vessels” (WHO, 2017). Unfortunately, there is no clear consensus as to which diseases fall 
into the category of CVD. This becomes an issue when studying the literature regarding CVD, as 
it can be difficult to compare the prevalence of CVD published by organizations that define the 
term differently. For example, both the CDC and the AHA have published the prevalence of 
CVD in the United States. The CDC utilized the National Health Interview Survey (the same 
dataset that I use in my data analysis) and referred to CVD as “all types of heart disease” 
(Villarroel et al., Table A-1, 2019). The AHA utilized the National Health and Nutrition 
Examination Survey (NHANES) and referred to CVD as “total cardiovascular diseases” (Virani 
et al., 2020). Both includes a different subset of diseases under the category of CVD, as shown in 
Table 1.  
Table 1: Diseases that Qualify as CVD, According to the AHA and the CDC  
AHA* CDC** 
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Coronary heart disease Coronary heart disease 
Stroke Angina 
Heart failure Heart attack 
(Hypertension) "Any other heart condition or 
disease"  
*from the American Heart Association (AHA) Heart Disease and Stroke Statistics—2020 
Update (Ch. 13) (Virani et al., 2020) 
**from the Summary Health Statistics of the National Health Interview Survey, 2018, published 
by the Centers for Disease Control (CDC) (Villarroel et al., Table A-1, 2019) 
 
The CDC and AHA share only one specific condition under the umbrella term “CVD:” 
coronary heart disease, a condition caused by the buildup of plaque in the arteries surrounding 
the heart (AHA, "Coronary Artery Disease"). The two otherwise differ. The AHA includes 
stroke, a form of cerebrovascular disease that involves interruption of constant blood flow to the 
brain (American Association of Neurological Surgeons, “Cerebrovascular Disease”); and heart 
failure, which is when the heart reaches a state in which it is unable to pump a sufficient amount 
of blood to meet the body’s needs (National Heart, Lung and Blood Institute, “Heart Failure”). 
The AHA also classifies hypertension as a form of CVD, although it also includes data on CVD 
with the exclusion of hypertension. This is likely because hypertension is more commonly 
considered a risk factor for CVD than a form of CVD itself (Virani et al., 2020). The AHA 
defines hypertension, or chronically high blood pressure, as having a systolic blood pressure ≥ 
130 mmHg or a diastolic blood pressure ≥ 80 mmHg; as well as having been told twice by a 
health professional that one has high blood pressure (Virani et al., 2020). on the AHA website 
(AHA, "Understanding Blood Pressure Readings"). 
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The CDC classifies angina, severe chest pain caused by a lack of oxygen to the heart, and 
a heart attack, an event in which blood flow bringing oxygen to the heart is severely reduced or 
interrupted completely, as forms of CVD (AHA, “Angina (Chest Pain)” and “About Heart 
Attacks”; Villarroel et al., Table A-1, 2019). This is somewhat confusing, as both angina and 
heart attacks are considered indicators of coronary heart disease (which, to add to the confusion, 
is sometimes referred to as coronary artery disease, although the two are technically different) 
(CDC, "Coronary Artery Disease"). The CDC also includes the category of “any other heart 
condition or disease,” which is rather vague (Villarroel et al., Table A-1, 2019).  
A final issue with the term CVD is that often in population-based surveys, such as the 
NHIS and NHANES, only a few forms of CVD are specified (refer to Table 1). However, there 
are many types of diseases that fall under the category of CVD. For example, the WHO provides 
an extensive list of diseases that are considered forms of CVD. Consistent with NHIS and 
NHANES, this list includes coronary heart disease and cerebrovascular disease (such as stroke). 
However, the list goes on to include peripheral artery disease, rheumatic heart disease, congenital 
heart disease, and deep vein thrombosis (WHO, 2017). Thus, it is clear that the data from NHIS 
and NHANES are limited with regards to the many forms of CVD that exist.  
I hope that in the above paragraphs I illustrated the ambiguity surrounding the term 
“cardiovascular disease.” The AHA and CDC define CVD differently with varying diseases in 
each category. Additionally, many of these diseases overlap: for example, angina is categorized 
as a form of CVD by the CDC, but is also a symptom of coronary heart disease, another form of 
CVD. Finally, the list of diseases that qualify as forms of CVD is extensive, and few studies 
provide a comprehensive overview of all of these diseases.  
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Large Studies Show the Hispanic Population has a Lower Prevalence of CVD 
According to the 2020 Heart Disease and Stroke Statistics Update from the American 
Heart Association, the Hispanic population in the U.S. experiences lower rates of cardiovascular 
disease than the non-Hispanic population (Virani et al., 2020). As noted above, the AHA defines 
CVD as including coronary heart disease, heart failure and stroke. The AHA also includes rates 
of CVD with and without hypertension. As I regard hypertension as a risk factor for CVD more 
so than a form of CVD, I have reported the results that exclude hypertension. The AHA reports 
that 7.8% of Hispanic males and 8.0% of Hispanic females have CVD in the United States, the 
lowest prevalence in any racial/ethnic group other than Asians. NH white males and females 
have a CVD prevalence of 9.7% and 8.1%, respectively. NH black males and females have a 
CVD prevalence of 10.7% and 10.5%, respectively, the highest of any racial/ethnic group. NH 
Asian males and females have a prevalence of 6.5% and 4.6%, respectively (Virani et al., 2020). 
Data are not available for NH Alaskan Native/American Indian males and females, likely due to 
small sample size. When hypertension is included as a form of CVD, the CVD prevalence 
skyrockets. For example, within the Hispanic population, the prevalence of CVD when 
hypertension is included is 49.0% for males and 42.6% for females (Virani et al., 2020). 
Throughout my data analysis, I will exclude hypertension from CVD.  
The fact that fewer Hispanic individuals experience CVD than NH white and NH black 
individuals is especially perplexing due to the fact that Hispanics have high rates of obesity, 
hyperlipidemia (high cholesterol), and diabetes, three major risk factors for CVD. The AHA 
reports that NHANES data from the years 2011-2014 examining adults aged 20 years or older 
show that 73.6% of NH white males are either overweight or obese, while 64.3% of NH white 
females are overweight or obese (Virani et al., 2020). These rates, while startlingly high, are 
 22 
lower than those of the Hispanic population where 80.8% of Hispanic males and 77.8% of 
Hispanic females are either overweight or obese (Virani et al., 2020). NH black males have a 
lower rate of overweight/obesity than Hispanic males (69.1%) but NH black females have a 
higher rate (79.5%) (Virani et al., 2020). 
The Hispanic population also has a high rate of hyperlipidemia (defined as total 
cholesterol ≥ 200 mg/dL). Between 2013-2016, the rates of hyperlipidemia among Hispanic 
adults aged 20 years or older was 39.9% of Hispanic males and 38.9% of Hispanic females 
(Virani et al., 2020). This is higher than NH whites (where the prevalence was 35.4% among 
males and 41.8% amongst females), and NH blacks (where the prevalence was 29.8% and 
33.1%, respectively) (Virani et al., 2020). Thus, according to these two risk factors (obesity and 
hyperlipidemia) the Hispanic population is at an even greater risk for CVD than the NH white 
population. 
Finally, the Hispanic population has a high prevalence of diabetes, a major risk factor for 
CVD (Dokken, 2008). Data from the CDC, which utilizes the 2018 NHIS, the same dataset that I 
use, show that the prevalence of diabetes in the Hispanic population is 13.2% (Villarroel et al., 
Table A-4, 2019). This far exceeds that of the NH white population, which is 8.0%. The NH 
black population has a prevalence of 13%, while the Alaskan Native/American Indian population 
has a rate of 23.5% and the Asian population has a rate of 11.4% (Villarroel et al., Table A-4, 
2019). Thus, the following question presents itself: how is it possible that the Hispanic 
population in the U.S. has a lower prevalence of CVD than NH white and NH black populations, 
given that this population has a higher prevalence of major risk factors (specifically the increased 
rates of overweight/obesity, hyperlipidemia, and diabetes)?   
Some Small Studies Challenge the HHP with respect to CVD 
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While many studies support the existence of the HHP with respect to CVD, other studies 
challenge its existence. For example, Joshua Z. Willey and colleagues examined 2,671 
participants in the Northern Manhattan Study (NOMAS), a population-based study that recruited 
individuals aged over 39 years with no history of stroke (2012). At the beginning of Willey’s 
study, none of the participants had clinical CVD. Willey et al. found that Hispanic participants 
were at a paradoxically lower risk of coronary deaths and vascular deaths (two forms of CVD) 
than NH white and NH black participants; however, they did not have a lower risk of nonfatal 
myocardial infarction (MI; also known as a heart attack). The Willey study is unique in two main 
ways: the majority of the Hispanic cohort examined was made up of Caribbean Hispanics, 
whereas many other studies primarily examine Mexican-Americans. Secondly, it is one of the 
few studies that examines specific cardiovascular outcomes, such as coronary death, vascular 
deaths and nonfatal MI; many other studies solely use the umbrella term “cardiovascular 
disease” (Willey et al., 2012). This study points out that the HHP must be examined through a 
lens which considers the country-of-origin of Hispanics, as well as particular cardiovascular 
outcomes rather than CVD as a whole.  
 The San Antonio Heart Study presents some of the strongest evidence against the 
Hispanic health paradox (Hunt et al., 2002). During the study 827 individuals with diabetes were 
examined over an approximately ten-year period. Hunt and colleagues found that U.S.-born 
Mexican Americans were at a greater risk of all-cause and cardiovascular mortality compared to 
NH whites, whereas Mexico-born Mexican Americans were at a similar risk (Hunt et al., 2002). 
These results directly oppose those that would be predicted on the basis of the HHP, where 
Mexican Americans would have had lower rates of all-cause and cardiovascular mortality than 
NH whites. It is notable that this study only examined diabetic individuals, and found evidence 
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that contradicts the HHP. This calls for more research into the HHP that takes CVD risk factors, 
such as diabetes, into consideration.   
 Lastly, a study conducted by Dilip K. Pandey and colleagues in Corpus Christi, Texas, 
compared the coronary heart disease mortality between 785 Mexican Americans and 862 NH 
white women and men (2001). Pandey et al. found that coronary heart disease mortality was 
greater amongst Mexican Americans than NH whites (although the results were not statistically 
significant amongst men). These data go against the prevailing reports that Mexican Americans 
have lower rates of mortality from coronary heart disease (Pandey et al., 2001). Similarly to the 
study of Hunt et al., the Corpus Christi study directly refutes the HHP with regards to CVD.  
 
A Call for More Research 
 As the above studies show, there is a need for more research related to the Hispanic 
health paradox. There is great debate over whether or not the HHP actually exists, or is merely a 
function of under-reporting of negative Hispanic health outcomes. Abraído-Lanza et al. showed 
that the salmon bias hypothesis and the healthy migrant hypothesis cannot account for the 
Hispanic mortality paradox, but similar analyses need to be conducted with respect to other 
manifestations of the HHP (1999). Additionally, there is question as to whether or not the 
Hispanic population truly has a health advantage over the NH white population, or if the low 
prevalence of CVD is due to the high proportion of immigrants in this population. Finally, there 
is conflicting data as to whether or not the HHP exists with respect to CVD. Two large-scale 
studies, utilized by the AHA and CDC, show that Hispanic individuals have a lower prevalence 
of CVD than NH white individuals (Virani et al., 2020; Villarroel et al., Table A-1, 2019). 
However, smaller studies led by Willey, Hunt and Pandey show the opposite (2012, 2002, 2001).   
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In order to expand upon the body of research exploring these aspects of the HHP, I will 
focus on two points of study in the scope of my analysis. The first point of study is that the 
impact of CVD risk factors on the prevalence of CVD in the Hispanic population, with respect to 
other racial/ethnic groups, is largely unknown. As shown in the San Antonio Heart Study, some 
data suggests that the HHP does not exist in the population with diabetes, a major risk factor for 
CVD (Hunt et al., 2002).  In order to explore if this holds true nationally, throughout my data 
analysis I will ask the question: is the HHP (with respect to CVD) observed among populations 
with diabetes? This will be assessed by determining if Hispanic populations with diabetes still 
have a lower prevalence of CVD than NH white populations and NH black populations with 
diabetes, as they do in the general population.  
 The second point of study that requires more data in order to understand is the impact of 
country-of-origin on the HHP. The healthy migrant hypothesis suggests that the prevalence of 
CVD in the Hispanic population is low due to a high proportion of immigrants within this 
population. In order to either support or refute this hypothesis, I will examine the prevalence of 
CVD within U.S.-born and foreign-born Hispanic populations. I will ask the question: is the 















CHAPTER III: METHODS 
 
Introduction 
I utilized data from the National Health Interview Survey (NHIS), a cross-sectional survey of the 
civilian, non-institutionalized population in the United States. This data is made available 
through the IPUMS database (Blewett et al., 2019). It is conducted annually by the National 
Center for Health Statistics (NCHS), a branch of the Centers for Disease Control and Prevention 
(CDC) (National Center for Health Statistics, “About the National Health Interview Survey”). I 
looked specifically at the year 2018 in my data analysis, in which the total number of 
respondents was 72,226 individuals. Interviews are voluntary and conducted in person, and one 
adult from each household is randomly selected to complete the Sample Adult component of the 
survey. The majority of my analysis focused specifically on respondents within the Sample Adult 
condition. More information regarding the methodology of the NHIS is published elsewhere 
(National Center for Health Statistics, “About the National Health Interview Survey”). I used 
StataIC 16.0 to analyze the data.  
 
Results  
The Hispanic Population Has a Comparably Low CVD Prevalence 
I will begin by showing that the Hispanic population consistently has a lower prevalence of CVD 
than the NH white population, NH black population, and NH Alaskan Native/American Indian 
population. Figure 1 shows that the prevalence of CVD in the Hispanic population (8.02%) is 
about half that of the NH white population (16.1%). The Hispanic population also has a lower 
prevalence of CVD than the NH black (12.1%) and NH Alaskan Native/American Indian 
(15.5%) populations. This low prevalence of CVD within the Hispanic population, compared to 
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other racial/ethnic groups, show that the Hispanic health paradox is present with respect to CVD 
in the general population (Figure 1 and Table 1). The prevalence of CVD within the NH Asian 
population (8.36%) is about the same as that of the Hispanic population, indicating that the HHP 
is not present with respect to the NH Asian population.  
Figure 1: Prevalence of CVD by Race/Ethnicity, 2018.  
 
 
Table 1: Prevalence of CVD, 95% CI and p-value in General Population, 2018 
Race/Ethnicity No. Prevalence 
of CVD 





NH White*** 20,608 0.161 0.154-0.167 0.0804677 0.000 




322 0.155 0.107-0.203 0.0750634 0.003 
NH Asian 1,643 0.084 0.067-0.100 0.0033862 0.738 
Hispanic (ref) 3,958 0.080 0.069-0.091 -- -- 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 

























Hispanic White Black Alaskan Native/American Indian Asian
*** 
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The data shown in Figure 1 and Table 1 are similar to CVD data published by the CDC, which 
also utilized the 2018 NHIS (the same dataset that I analyzed). The CDC reports the prevalence 
of CVD for the following populations: Hispanic population 8.2%, NH white population 12.2%, 
NH black population 10.0%, Alaskan/Native population 14.6%, and Asian population 7.7% 
(Villarroel et al., Table A-1, 2019). The prevalence of CVD within the Hispanic population in 
this analysis is very similar to that reported by the CDC (with only a 0.18% difference). The 
CDC reported a slightly lower prevalence of CVD in the NH white and NH black populations 
than my analysis shows. This difference could be due to the fact that I included stroke when 
calculating the prevalence of CVD, while the CDC did not. I chose to do this because stroke is 
often regarded as a form of CVD (for example, it is classified as such by the American Heart 
Association, as discussed in the literature review) (Virani et al., 2020). Finally, the CDC analysis 
also shows a lower prevalence of CVD in the Alaskan Native/American Indian and Asian 
populations than my analysis. Data regarding the non-Hispanic subsets of these populations is 
not available, but likely would not differ significantly. Again, this difference is likely because I 
included stroke as a form of CVD in my analysis.   
Age 
In order to show that the Hispanic health paradox is not limited to the general population as a 
whole, I examined sub-populations that differ in terms of age, income and education level. 
Figure 2 and Table 2 show the prevalence of CVD within three age ranges in each racial/ethnic 
population: 18-44, 45-64, and 65 and older. The Hispanic population consistently has a 
statistically-significant lower prevalence of CVD than the NH white population within all three 
age groups. The Hispanic population also has a lower prevalence of CVD than the NH black and 
NH Alaskan Native/American Indian populations. These differences are statistically significant 
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in the older two age groups but not the youngest. Finally, the Hispanic population has a slightly 
higher prevalence of CVD than the NH Asian population in the first two age groups, but a 
slightly lower prevalence in the oldest age group. None of these differences are statistically 
significant. This breakdown shows that after controlling for age, the Hispanic population has 
lower rates of CVD than NH white, NH black, and NH Alaskan Native/American Indian 
populations, but not necessarily NH Asian populations.  




Table 2: Prevalence of CVD, 95% CI and p-value in General Population by Age, 2018 
Age 
Range 
Race/Ethnicity No. Prevalence of 
CVD 





18-45 NH White** 7,190 0.060 0.052-0.068 0.019 0.009 


































161 0.070 0.018-0.122 0.029 0.290 
NH Asian 810 0.034 0.018-0.050 -0.007 0.481 
Hispanic (ref) 2,260 0.041 0.029-0.053 -- -- 
45-64 NH White*** 7,190 0.149 0.138-0.160 0.054 0.000 




100 0.197 0.097-0.297 0.102 0.048 
NH Asian* 505 0.055 0.033-0.077 -0.040 0.010 
Hispanic (ref) 1,098 0.095 0.074-0.117 -- -- 
65+ NH White*** 6,228 0.342 0.327-0.357 0.088 0.000 




61 0.437 0.297-0.577 0.183 0.015 
Asian 328 0.308 0.244-0.372 0.053 0.167 
Hispanic (ref) 600 0.254 0.209-0.299 -- -- 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 
“No.” refers to the total number of individuals sampled within each group. 
 
Income Level 
I also broke down the general population by income level in order to determine if the HHP 
shown in Figure 1 holds true after controlling for income. As shown in Figure 3, the Hispanic 
population has a lower prevalence of CVD across all five income levels than the NH white 
population. All of these differences are statistically significant. This difference is greatest in the 
lowest two income categories. In the $0-$34,999 category, the prevalence of CVD in the 
Hispanic population (11.55%) is slightly over half that of the NH white population (22.90%) 
(Figure 3). In the $35,000-$49,999 income category, the prevalence of CVD in the Hispanic 
population is only 6.33%, a third of the NH white population at 19.79% (Table 3). This trend 
persists in the remaining three income categories, with the Hispanic population always having a 
prevalence of CVD at least 6% less than the NH white population. Thus, it is clear that across 
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income levels, the Hispanic population has a lower prevalence of CVD than the NH white 
population. 
 The Hispanic population also has a lower prevalence of CVD than the NH black 
population (Figure 3). This difference is less dramatic than between the Hispanic and NH white 
population, but still present. This difference is greatest in the second-highest income category, 
$75,000-$99,999, in which the prevalence of CVD within the Hispanic population (5.63%) is 
over 7% less than the NH black population (12.82%) (Table 3). While the Hispanic population 
still has a lower rate of CVD than the NH black population in the middle income category, this 
difference is not statistically significant. With the exception of the middle income category 
($50,000-$74,999), the Hispanic population always has a statically-significant lower prevalence 
of CVD than the NH black population.  
 The Hispanic population also has a lower prevalence of CVD compared to the NH 
Alaskan Native/American Indian populations across all income levels, although this difference is 
not statistically significant. While there are fluctuations between different income levels, the 
Hispanic population generally has a similar prevalence of CVD as the NH Asian population. 
This is consistent with the data presented in Figures 1 and 2 regarding the general population as 
well as the age-specific populations. While the Hispanic population has similar rates of CVD to 
the Asian population across income levels, it does have a health advantage over the NH white, 










Table 3: Prevalence of CVD, 95% CI and p-value by Total Family Income, 2018 
Income 
Level 
Race/Ethnicity No. Prevalence of 
CVD 








NH White*** 4,998 0.229 0.214-0.244 0.114 0.000 
Black** 1,574 0.170 0.145-0.195 0.0548 0.001 
Alaskan Native/ 
American Indian 
167 0.179 0.098-0.259 0.0632 0.131 
Asian 370 0.107 0.071-0.143 -0.008 0.693 
Hispanic (ref) 1,464 0.115 0.095-0.136 -- -- 
$35,000-
$49,999 
White*** 2,023 0.198 0.176-0.220 0.135 0.000 






Asian* 130 0.160 0.070-0.250 0.097 0.043 
Hispanic (ref) 494 0.063 0.037-0.090 -- -- 
$50,000-
$74,999 
White*** 3,113 0.162 0.146-0.178 0.066 0.000 
Black 483 0.107 0.076-0.139 0.012 0.620 
Alaskan Native/ 
American Indian 
35 0.179 0.037-0.321 0.083 0.264 



































Hispanic (ref) 565 0.096 0.020-0.092 -- -- 
$75,000-
$99,999 
White*** 2,704 0.138 0.122-0.154 0.081 0 






Asian 196 0.088 0.040-0.135 0.031 0.304 
Hispanic 358 0.056 0.020-0.092 n/a n/a 
$100,000+ White*** 5,469 0.110 0.100-0.120 0.081 0 







Asian 540 0.059 0.035-0.083 0.031 0.304 
Hispanic (ref) 543 0.045 0.026-0.065 -- -- 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 
“No.” refers to the total number of individuals sampled within each group. 
 
Education Level  
Finally, I divided the general population by education level in order to determine if the HHP 
(that is, the Hispanic population has a lower rate of CVD than NH white, NH black, and NH 
Alaskan Native/American Indian populations) is still present after controlling for education. As 
shown in Figure 4, the Hispanic population consistently has a significantly lower prevalence of 
CVD than the NH white population in every education level. As with income, these differences 
are greatest in the lowest two education levels. Amongst individuals who never graduated high 
school, the prevalence of CVD within the Hispanic population (9.52%) is 15% less than in the 
NH white population (24.58%). Amongst individuals who received a high school diploma or the 
equivalent, the prevalence of CVD within the Hispanic population is 9.80% less than the NH 
white population. The gaps between the two populations are smaller in the remaining three 
educational categories, but never dip below 4%. Thus, it is clear that across all education levels, 
the Hispanic population has a lower prevalence of CVD than the NH white population.  
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The same is true for the NH black population—across all education levels, the Hispanic 
population has a lower prevalence of CVD than the NH black population. While this difference 
is not statistically significant in the two highest education categories (bachelor’s degree and 
master’s degree or higher), it is in the remaining three education categories. As with the NH 
white population, the difference between the Hispanic population and NH black population is 
highest in the group that never graduated high school. Within this population, the prevalence of 
CVD within the NH black population is 13.52%, over 9% greater than the Hispanic population at 
9.52% (Table 4). Thus, the data show that the prevalence of CVD within the Hispanic population 
is less than the NH white and black populations across all education levels.  
The relationship between the Hispanic population and the NH Alaskan Native/American 
Indian population is less consistent. In some categories, the two appear to have a similar level of 
CVD, whereas in other categories, the NH Alaskan Native/American Indian population has much 
higher prevalence of CVD. Regardless, the difference between the two populations is not 
statistically significant in any education level. The difference between the Hispanic population 
and the NH Asian population is also not statistically significant at any education level. (Figure 
4). The two populations appear to have a similar prevalence of CVD in the highest three 
educational categories, while the NH Asian population has a higher prevalence of CVD in the 
lower two educational categories. Unfortunately, due to the lack of statistical significance, it is 
difficult to determine the nature of the relationship between the Hispanic, NH Alaskan 








Figure 4: Prevalence of CVD by Education Level, 2018 
 
 
Table 4: Prevalence of CVD, 95% CI and p-value by Education Level, 2018 
Education 
Level 
Race/Ethnicity No. Prevalence 
of CVD 








White*** 1,490 0.246 0.218-0.273 0.151 0.000 
Black*** 570 0.192 0.143-0.242 0.097 0.000 
Alaskan Native/ 
American Indian 
60 0.213 0.789-0.348 0.118 0.087 
Asian 118 0.163 0.074-0.252 0.068 0.15 




White*** 5,042 0.182 0.167-0.196 0.098 0.000 
Black** 1,026 0.135 0.108-0.162 0.052 0.006 
Alaskan Native/ 
American Indian 
113 0.086 0.038-0.135 0.003 0.928 
Asian 246 0.113 0.059-0.166 0.029 0.309 





White*** 6,349 0.160 0.148-0.172 0.093 0.000 




92 0.253 0.110-0.396 0.186 0.012 
Asian 328 0.062 0.032-0.092 -0.005 0.783 
Hispanic (ref) 993 0.067 0.048-0.086 -- -- 













































Black 522 0.076 0.051-0.102 0.004 0.847 
Alaskan Native/ 
American Indian 
36 0.080 -0.015-0.175 0.008 0.883 
Asian 515 0.080 0.054-0.107 0.008 0.717 





White** 2,821 0.141 0.125-0.156 0.072 0.001 
Black 288 0.093 0.055-0.131 0.025 0.36 
Alaskan Native/ 
American Indian 
19 0.060 -0.057-0.177 -0.008 0.894 
Asian 410 0.060 0.032-0.089 -0.008 0.728 
Hispanic (ref) 214 0.067 0.031-0.107 -- -- 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 
“No.” refers to the total number of individuals sampled within each group. 
 
In conclusion, the Hispanic population consistently has a lower prevalence of CVD than 
the NH white and NH black populations after controlling for age, income level and education 
level. The difference between the Hispanic population and the NH white population is greatest 
and was statistically significant in each of the analyses performed. The Hispanic population has a 
lower prevalence of CVD than the NH Alaskan Native/American Indian population after 
controlling for age. This seems to be the case across income level and education level as well, 
but this is difficult to determine due to the lack of statistical significance. The Hispanic 
population has similar levels of CVD compared to the NH Asian population within different age 
groups, income levels and education levels.  
 
Populations with Diabetes: Hispanic Population Still Has Comparably Low CVD Prevalence  
After establishing that the Hispanic population has lower rates of CVD than the NH white and 
NH black populations (and, with less certainty, the NH Alaskan Native/American Indian 
populations), I will now examine the rates of CVD amongst individuals with diabetes. As 
described in the literature review, there is a lack of research that examines the HHP in the 
context of populations at risk for CVD. Diabetes is a major risk factor for cardiovascular disease, 
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so I expect to see higher rates of CVD within this population than the general population. The 
data are consistent with this expectation. Figure 5 shows that the prevalence of CVD within 
populations with diabetes is, on average, 16% higher than in the general population. The 
Hispanic population with diabetes has a lower prevalence of CVD than the NH white population 
with diabetes. This is consistent with the rates of diabetes in the general population, although the 
difference between the two racial/ethnic groups is less dramatic in the population with diabetes. 
The prevalence of CVD in the Hispanic population with diabetes is 24.30%, about two-thirds of 
the prevalence of CVD in the NH white population with diabetes at 36.35% (Table 5). This 
difference, though large, is less than in the general population, in which the prevalence of CVD 
in the Hispanic population is half that of the NH white population.  
 The Hispanic population with diabetes also has a lower prevalence of CVD (24.30%) 
than the NH black population with diabetes (30.34%). This too is consistent with the general 
population, although the difference in the population with diabetes is smaller and not statistically 
significant. The prevalence of CVD amongst Hispanic individuals (8.02%) is only one-third 
smaller than the prevalence of CVD amongst NH black individuals (12.14%) in the general 
population (Table 1). However, the prevalence of CVD amongst Hispanic individuals with 
diabetes (24.30%) is only one-fifth smaller than the prevalence of CVD amongst black 
individuals with diabetes (30.4%) (Table 5).  
 The prevalence of CVD in the Hispanic population with diabetes is very similar to the 
NH Alaskan Native/American Indian populations with diabetes (24.09%) (Figure 5). This is 
different from the relationship between the two in the general population, in which the 
prevalence of CVD amongst Alaskan Native/American Indian population is about twice that of 
the Hispanic population (Figure 1). The incongruency could be due to small sample size. The 
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NH Alaskan Native/American Indian population only consists of 857 individuals, while the 
population with diabetes only consists of 132 individuals. The prevalence of CVD within the 
Hispanic population with diabetes is similar to that of the NH Asian population with diabetes 
(25.98%), consistent with what is seen in the general population (Figure 5).  
Figure 5: Prevalence of CVD in Individuals with Diabetes by Race/Ethnicity, 2018 
 
 
Table 5: Prevalence of CVD, 95% CI and p-value in Individuals with Diabetes, 2018 
Race/Ethnicity No. Prevalence of 
CVD 




White*** 2,304 0.363 0.341-0.386 0.121 0.000 




63 0.241 0.122-0.359 -0.002 0.974 
Asian 202 0.260 0.186-0.333 0.017 0.700 
Hispanic (ref) 501 0.243 0.198-0.288 -- -- 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 






























Prevalence of CVD in Populations with Diabetes Across 
Race/Ethnicity, 2018




Next, in order to show that the Hispanic population with diabetes does not have lower rates of 
CVD than the NH white, NH black, and NH Alaskan Native/American Indian populations solely 
due to a disproportionate number of older individuals, I controlled for age by comparing each 
population in age-specific groups. Figure 6 shows that Hispanic individuals with diabetes have a 
lower prevalence of CVD than NH white individuals with diabetes in each age category. The 
greatest difference is within the 45-64 age group, with the prevalence of CVD amongst 
Hispanics with diabetes at 19.3% compared to the NH population at 30.6%. The difference in the 
youngest age group is not, however, statistically significant (Table 6). The Hispanic population 
with diabetes also has a lower prevalence of CVD than the NH black population with diabetes, 
although these differences are also not statistically significant.  
 The relationship between the prevalence of CVD within the Hispanic and the NH 
Alaskan Native/American Indian populations with diabetes is somewhat variable. In the 18-44 
and 65+ age groups, the NH Alaskan Native/American Indian population with diabetes has a 
lower rate of CVD, whereas in the 45-64 age group the Hispanic population with diabetes has a 
lower rate of diabetes (Figure 6). As with the NH black population with diabetes, none of these 
differences are statistically significant. The relationship between CVD prevalence in the 
Hispanic population with diabetes and the NH Asian population with diabetes is similarly 











Figure 6: Prevalence of CVD in Individuals with Diabetes by Age, 2018.  
 
Table 6: Prevalence of CVD, 95% CI and p-values in Individuals with Diabetes by Age, 2018 
Age 
Range 
Race/Ethnicity  No. Prevalence of 
CVD 




18-44 White 235 0.137 0.087-0.188 0.010 0.842 




16 0.087 -0.043-0.216 -0.040 0.607 
Asian 38 0.250 0.073-0.427 0.123 0.216 
Hispanic (ref) 84 0.127 0.041-0.213 -- -- 
45-64 White** 841 0.306 0.271-0.341 0.113 0.003 




22 0.285 0.047-0.524 0.092 0.467 
Asian 78 0.138 0.055-0.220 -0.056 0.304 
Hispanic (ref) 208 0.193 0.130-0.256 -- -- 
65+ White* 1,228 0.477 0.442-0.511 0.087 0.046 




25 0.375 0.169-0.582 -0.014 0.901 
Asian 86 0.402 0.291-0.513 0.012 0.865 



























Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 
“No.” refers to the total number of individuals sampled within each group. 
 
In conclusion, the Hispanic population with diabetes has a lower prevalence of CVD than 
the NH white and NH black populations with diabetes, but to a lesser degree than in the general 
population. This relationship is true across age groups, although the differences between the 
Hispanic population with diabetes and NH black population with diabetes are not statistically 
significant within individual age groups. The prevalence of CVD within the NH Alaskan 
Native/American Indian population with diabetes is similar to that of the Hispanic population 
with diabetes, defying what is seen in the general population. Within the individual age groups, 
the prevalence of CVD in the NH Alaskan Native/American Indiam populations fluctuates with 
respect to the NH Hispanic population with diabetes. The relationship between the Hispanic and 
NH Asian populations with diabetes is similar to in the general population: the prevalence of 
CVD are about the same between the two racial/ethnic groups. However, as with the NH 
Alaskan Native/American Indian population with diabetes, the differences in CVD prevalence 
between the NH Asian and Hispanic populations fluctuate greatly between age classes. Although 
the data regarding NH Alaskan Native/American Indian populations are variable, the Hispanic 
population still has a lower prevalence of CVD than the NH white and NH black populations 
with diabetes.  
 
U.S.-Born and Foreign-Born Hispanic Population Has Comparably Low Prevalence of CVD 
I will now consider the prevalence of CVD within populations born in the United States (U.S.-
born) and born outside the United States (foreign-born). Unsurprisingly, the prevalence of CVD 
in the U.S.-born population is very similar to the prevalence of CVD in the general population 
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(within 1.5% in each racial/ethnic group) (Figure 1, Figure 7). As in the general population, the 
U.S.-born Hispanic population has a lower prevalence of CVD (9.27%) than the U.S.-born NH 
white (16.25%), NH black (13.16%) and NH Alaskan Native/American Indian (16.47%) 
populations.  
Each of the racial/ethnic groups has a lower prevalence of CVD within the foreign-born 
population, with the exception of NH Asian. This is consistent with the healthy migrant 
hypothesis, which postulates that immigrants are subject to selection and therefore are healthier 
than average (Abraído-Lanza et al., 1999). The prevalence of CVD within the foreign-born NH 
Alaskan Native/American Indian population is 0%, because out of the 28 individuals who 
identify as NH Alaskan Native/American Indian and were born outside of the U.S, none of them 
had CVD. Amongst foreign-born individuals, the Hispanic population still has a lower 
prevalence of CVD than the NH white population. As in the U.S.-born population, the 
prevalence of CVD in the foreign-born Hispanic population is about half that of the foreign-born 
NH white population (Table 7). Conversely to the U.S.-born population, foreign-born Hispanic 
individuals have a higher rate of CVD than foreign-born NH black individuals. Additionally, 
because the rate of CVD within the NH Asian population stayed relatively constant across U.S.-
born and foreign-born individuals, Hispanics went from having a relatively higher rate of CVD 
in the U.S.-born population to a relatively lower rate of CVD in the foreign-born population 






Figure 7: Prevalence of CVD by Region of Birth in 2018 
 
 
Table 7: Prevalence of CVD, 95% CI and p-value by Region of Birth, 2018 
Region of 
Birth  
Race/Ethnicity  No. Prevalence of 
CVD 





US Born White*** 19,513 0.162 0.156-0.169 0.070 0.000 




307 0.165 0.120-0.220 0.072 0.014 
Asian 378 0.081 0.045-0.117 -0.012 0.557 
Hispanic (ref) 1,952 0.093 0.076-0.110 -- -- 
Foreign 
Born 
White*** 1,044 0.132 0.106-0.158 0.063 0.000 




15 0 (omitted) -0.069 0.000 




































Hispanic (ref) 1,972 0.069 0.055-0.082 -- -- 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 
“No.” refers to the total number of individuals sampled within each group. 
 
Age 
Figure 8 shows that the U.S.-born Hispanic population consistently has a lower prevalence of 
CVD than the U.S.-born NH white population, across all three age ranges. However, these 
differences are not statistically significant. In fact, none of the differences between the U.S.-born 
Hispanic populations and the other U.S.-born racial/ethnic groups are statistically significant 
except with respect to NH Asians in the 45-64 age group, and with respect to NH Alaskan 
Native/American Indians in the 65+ age group. Although these results are not significant, the 
U.S.-born Hispanic population has a lower prevalence of CVD than the NH black population in 
the 45-64 and 65+ age groups, but not the 18-44 age group. These results are consistent with 
those shown in the age-specific prevalence of CVD in the general population, shown in Figure 2. 
Thus, the prevalence of CVD within the U.S.-born population supports the Hispanic health 


















Figure 8: Prevalence of CVD in U.S.-Born Individuals by Age, 2018 
 
 
Table 8: Prevalence of CVD in U.S.-Born Individuals by Age, 2018 
Age 
Range 
Race/Ethnicity  No. Prevalence 
of CVD 





18-44 White 164 0.061 0.053-0.068 0.009 0.36 
Black 47 0.050 0.035-0.065 -0.001 0.915 
Alaskan Native/ 
American Indian 
4 0.076 0.014-0.137 0.025 0.454 
Asian 12 0.038 -0.002-0.078 -0.013 0.561 
Hispanic (ref) 56 0.051 0.033-0.070 -- -- 
45-64 White 252 0.152 0.141-0.163 0.018 0.404 
Black 42 0.158 0.130-0.186 0.024 0.342 
Alaskan Native/ 
American Indian 
4 0.202 0.091-0.312 0.067 0.262 
Asian* 5 0.044 -0.014-0.101 -0.091 0.011 
Hispanic (ref) 24 0.135 0.095-0.175 -- -- 
65+ White 375 0.345 0.330-0.360 0.041 0.259 




5 0.451 0.302-0.601 0.148 0.08 
Asian 8 0.336 0.212-0.461 0.032 0.656 



























Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 
“No.” refers to the total number of individuals sampled within each group. 
 
While foreign-born individuals consistently have lower rates of CVD than U.S.-born individuals 
(Figures 8 and 9), the foreign-born Hispanic population consistently has lower rates of CVD than 
the foreign-born NH white population. While these differences are not statistically significant, 
the trend is consistent across all three age groups. Thus, the HHP is still shown between the 
Hispanic and NH white populations. However, the foreign-born Hispanic population has a higher 
prevalence of CVD than the foreign-born NH black population (Table 9). This is a different trend 
then has been seen before, as the NH black population has generally had a higher prevalence of 
CVD than the Hispanic population (including when broken down by income level, education 
level, and diabetes status). As consistently shown throughout this data analysis, the relationship 
between the Hispanic population and the NH Asian population is variable amongst foreign-born 
individuals (Figure 9). In conclusion, the foreign-born Hispanic population has a lower 
prevalence of CVD than the foreign-born white population, consistent with the U.S.-born 
population; however, the foreign-born Hispanic population has a higher prevalence of CVD than 









Figure 9: Prevalence of CVD in Foreign-Born Individuals by Age, 2018  
 
 
Table 9: Prevalence of CVD in Foreign-Born Individuals by Age, 2018 
Age 
Range 
Race/Ethnicity  No. Prevalence 
of CVD 






18-44 White 3 0.0450279 0.019-
0.071 
0.0172728 0.246 





0 0 (omitted) -0.0277551 0.000 
Asian 5 0.0325403 0.016-
0.049 
0.0047852 0.661 
Hispanic (ref) 9 0.0277551 0.015-
0.041 
-- -- 
45-64 White 16 0.101792 0.063-
0.140 
0.02624 0.27 





 0 (omitted) -0.075552 0.000 
Asian 31 0.0571522 0.032-
0.082 
-0.0183998 0.317 
Hispanic (ref) 52 0.075552 0.049-
0.102 
-- -- 























Hispanic NH White NH Black NH Alaskan Native/American Indian NH Asian
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0 0 (omitted) -0.214809 0.000 
Asian 22 0.3011984 0.224-
0.379 
0.0863893 0.067 
Hispanic (ref) 30 0.214809 0.164-
0.265 
-- -- 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed t-test. 
“No.” refers to the total number of individuals sampled within each group. 
 
While the above results present evidence for the Hispanic health paradox, they are limited in that 
they do not control for a number of variables. In order to do so, a multivariate logistic regression 
accounting for diabetes, age, imputed income, education, health status, region of birth, and sex 
was performed. Region of birth was taken into account in terms of region within the U.S. (which 
the NHIS divided into Northeast, North Central/Midwest, South, and West); and based on 
whether or not respondents were U.S.-born or foreign-born (using the USBORN variable, as 
previously described). One of the limitations of the income variable used previously in this 
analysis is that it excludes about 10% of the total sample. In order to address this limitation, I 
used the natural logarithm of imputed incomes in the multivariate logistic regression, using the 
income values attributed to each respondent by the NHIS (IPUMS, “INCIMPPOINT1”). Only 
individuals in the Sample Adult condition were included in the multivariate logistic regression. 
Additionally, only four racial/ethnic categories were used (opposed to five in the other analyses): 
Hispanic, NH white, NH black, and NH “other.” 
 
 
Table 10: Odds Ratios (95% CI) of CVD Among Hispanic and NH White Individuals Aged 18 
and Older, 2018 
Variable Hispanic NH White 
Diabetes  1.89*** 1.69*** 
 1.32-2.69 1.49-1.92 
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Age 1.03*** 1.04*** 
 1.02-1.05 1.04-1.05 
Ln(Income) 0.89 0.93* 
 0.78-1.02 0.88-0.99 
Education: No Diploma / GED (ref)   
High School Diploma / GED 1.16 0.90 
 0.77-1.74 0.74-1.09 
Associates Degree 1.31 0.95 
 0.78-2.22 0.75-1.20 
Bachelor’s Degree 1.80 0.93 
 0.96-3.35 .75-1.17 
Master’s Degree or Higher  1.06 0.99 
 0.46-2.45 0.78-1.25 
Health : Excellent (ref)   
Very Good  1.58 1.34** 
 0.74-3.34 1.12-1.60 
Good 1.80 2.37*** 
 0.89-3.66 1.99-2.82 
Fair  7.11*** 3.93*** 
 3.44-14.68 3.20-4.82 
Poor 17.73*** 6.83*** 
 7.96-39.52 5.23-8.92 
No. Observations 3,112 17,390 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed z-test. 
 
Table 10 shows that individuals with diabetes are more likely than individuals without diabetes 
to have CVD, consistent with the previously shown data. NH white individuals with diabetes are 
1.69 times more likely to have CVD than NH white individuals without diabetes, while Hispanic 
individuals with diabetes are 1.89 times more likely to have CVD than Hispanic individuals 
without diabetes. As age increases, both NH white and Hispanic individuals are slightly more 
likely to have diabetes. This, too, is consistent with the previously shown data.  
 
Table 11: Odds Ratios (95% CI) of CVD Among Individuals Aged 18 and Older by 
Race/Ethnicity, 2018 
Hispanic (ref) NH White NH Black NH Other 
-- 1.48** 1.02 1.250 
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-- 1.14-1.92 .76-1.38 .91-1.72 
Note: * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 (statistically different 
from the Hispanic population). Statistical significance was evaluated using a two-tailed z-test. 
 
Table 11 shows that after controlling for the specified variables, NH white individuals are 1.48 
times more likely to have CVD than Hispanic individuals, while NH black individuals are 1.02 
times more likely to have CVD than Hispanic individuals (although this difference is not 
statistically significant). Thus, the multivariate linear regression shows that Hispanic individuals 
maintain a health advantage over NH white individuals with respect to CVD. Additional analysis 
showed that when controlling for these specific variables, the prevalence of CVD within the NH 
white population is 13.6%, while the prevalence of CVD within the Hispanic population is 




Within the general population, the Hispanic population has a lower prevalence of CVD than the 
NH white and NH black populations after controlling for age, income level and education level. 
Within the population with diabetes, the Hispanic population has a lower prevalence of CVD 
than the NH white and NH black populations but to a lesser degree than in the general 
population. Finally, the foreign-born Hispanic population has a lower prevalence of CVD than 
the foreign-born NH white population, but a similar if not higher prevalence of CVD compared 
to the foreign-born NH black population. The difference between the Hispanic and NH white 
groups is similar in both the foreign-born population and the general population—the Hispanic 





Race/Ethnicity: The NHIS provided several answer choices regarding race and ethnicity, which I 
consolidated into five groups: Hispanic, non-Hispanic (NH) white, NH black, NH Alaskan 
Native/American Indian, and NH Asian populations. The “Asian” category includes those who 
identify as Chinese, Filipino, Indian Asian, or “Other Asian” (IPUMS, “RACEA”). Hispanic 
individuals include anyone who identified as Mexican, Mexican-American, Puerto Rican, 
Cuban/Cuban American, Dominican, Other Hispanic, Central or South American, Other Latin 
American, Other Spanish, or Multiple Hispanic (IPUMS, “HISPETH)”. These answer choices 
were provided by the NHIS, and the answers to this question was self-reported. When generating 
the five categories used in this analysis, I placed anyone who identified as Hispanic into the 
“Hispanic” category. Each individual is in one (and only one) category. Following this 
categorization, the racial/ethnic breakdown consisted of 12,481 Hispanic individuals, 46,222 NH 
white individuals, 8,317 NH black individuals, 857 Alaskan Native/American Indian individuals, 
and 4,349 Asian individuals.  
 
Cardiovascular disease (CVD): I defined CVD as an umbrella term for any of the following: 
coronary heart disease, angina pectoris, heart attack (myocardial infarction), or stroke. I also 
included respondents who indicated that they had been diagnosed with “any kind heart condition 
or disease other than coronary heart disease, angina pectoris, or a heart attack” (IPUMS, 
“HEARTCONEV”). Although this description is ambiguous, I chose to include it because it is 
included in the CDC 2018 Summary Health Statistics report (Villarroel et al., Table A-1, 2019). 
Respondents were asked if they had ever been told by a doctor or other health care professional 
that they had one of the above listed conditions. 
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Income Level: When generating the income variable, I excluded 9,205 people. This was due to 
the NHIS survey set up. The variable provides “total group family income,” meaning the 
combined income of all family members before taxes. Respondents were asked if their total 
family income was in between $0-$34,999; $35,000-$49,999; $50,000-$74,999; $75,000-
$99,999; or $100,000 and over. However, respondents who could not provide precise 
information regarding their total family income were asked to estimate if their income was 
between $0-$49,000 or $50,000-$99,999. I excluded the 3,871 respondents who answered either 
$0-$49,000 or $50,000-$99,999, as I had no way of knowing which of the five smaller income 
categories they fell into. I also excluded anyone whose answer was categorized by the NHIS as 
“undefined” or “unknown.” After these exclusions, the total sample size was 63,626 respondents 
for the year 2018.  
 
Education Level: When generating the education variable, I excluded 5,057 people. I categorized 
survey respondents into the following categories: less than a high school education (includes 
anyone who never attended school, or who attended school but ended before receiving a diploma 
in 12th grade); high school education or equivalent (which includes anyone who graduated high 
school or obtained a GED or the equivalent); some college or an associates degree (which 
includes anyone who completed some college without receiving a degree, or anyone who 
completes an associates (AA) degree); bachelor’s degree; or anyone with a master’s, professional 
(such as MD or JD) or doctoral degree (such as PhD or EdD). Children under the age of five 
years old were not asked about their educational level and thus were excluded. I also excluded 
anyone whose education level was unknown. 
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Diabetes: Individuals were considered diabetic if they responded “yes” or “borderline” to the 
question “Have you ever been told by a doctor or health professional that you have diabetes or 
sugar diabetes?” Women were asked to exclude diabetes that occurred during pregnancy 
(IPUMS, “DIABETICEV”). Only 54% of NHIS respondents were asked this question (those that 
fell into the Sample Adult and Sample Children categories) (IPUMS, “DIABETICEV”). Of those 
who were asked the question, I excluded those whose response was interpreted as “unknown” 
within the NHIS. I also limited my analysis to adults aged 18 or older. After taking these steps, 
the total sample size of diabetic individuals was 7,266. The racial/ethnic breakdown was as 
follows: 989 Hispanic; 4,670 NH white; 1,100 NH black; 132 NH Alaskan Native/American 
Indian; and 375 NH Asian.  
 
Region of Birth: NHIS respondents were asked “Where were you born?” Throughout my 
analysis, I will refer to respondents that answered “born in U.S. state or D.C.” as U.S.-born. I 
will refer to those who answered “born in U.S. territory” or “born outside U.S. and U.S. 
territory” as Foreign-Born (IPUMS, “USBORN”). All those whose region of birth was recorded 
as “unknown” within the NHIS were excluded. The number of people in each category is as 
follows: 61,777 in the U.S.-born category and 10,784 in the foreign-born category.  
 
Statistical Analysis 
Sampling weights were used to account for the sampling design. For example, sampling weights 
were used to account for the fact that Hispanic, black and Asian individuals who were over 65 
years old were oversampled in the Sample Adult condition (National Center for Health Statistics, 
“About the National Health Interview Survey”). The NHIS data was accessed through a publicly-
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available database called IPUMS, which was previously an acronym for “Integrated Public Use 
Microdata Series” but is now known solely as IPUMS because not all of the organization’s data 
projects are for public use or contain microdata (IPUMS, “What is IPUMS?”). The sampling 
weight variable “SAMPWEIGHT” was utilized. A linear regression was used to determine the 






































CHAPTER IV: DISCUSSION 
Hispanic Population Has Low CVD Prevalence 
A much larger proportion of Hispanic individuals fell within the lowest income and 
education categories compared to NH white individuals in the 2018 National Health Interview 
Survey (NHIS) (see Appendix, Figures 1 and 2). Additionally, a comparable proportion of 
Hispanic individuals fell within the lowest income category compared to NH black individuals, 
and a greater proportion fell in the lowest education category (see Appendix, Figures 1 and 2). 
The socioeconomic status (SES)-health gradient would predict that the Hispanic population 
would have a higher prevalence of cardiovascular disease (CVD) than the non-Hispanic (NH) 
white population, and a comparable (if not higher) prevalence of CVD compared to the NH black 
population (Adler et al., 1994). However, the data do not show these relationships.    
The results of this data analysis show that the Hispanic population in the United States 
has a lower CVD prevalence than the NH white and NH black populations (Figure 1). This 
remains true even after controlling for age, as the Hispanic population consistently had a lower 
prevalence of CVD than the NH white and NH black populations in each age group, and all but 
one of these differences were statistically significant (Figure 2). The Hispanic population also 
had a significantly lower prevalence of CVD than the NH white population across all income and 
education categories (Figures 3 and 4). The same is true with respect to the NH black population, 
although not all differences were statistically significant. Thus, these results provide evidence of 
the existence of the Hispanic health paradox. 
The prevalence of CVD within the Hispanic, NH white and NH black populations found 
in this analysis are fairly consistent with those published by the American Heart Association 
(AHA) and Centers for Disease Control (CDC) (Virani et al., 2020; Villarroel et al., Table A-1, 
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2019). The only major difference between these results and those published by the AHA is the 
prevalence of CVD within the NH white population. While my analysis, which utilized data from 
the 2018 NHIS, found a prevalence of 16.1% in the NH white population, the AHA reports a 
prevalence of 9.7% among NH white males and 8.4% among NH white females (data for the 
overall population unavailable) (Virani et al., 2020). A possible explanation for this difference is 
that the AHA utilized data from the National Health and Nutrition Examination Survey 
(NHANES), a survey that has both an interview and a physical examination component. The 
NHANES is composed of about 5,000 people each year, which is about one-fourteenth the size 
of the NHIS sample I studied (National Center for Health Statistics, “About the National Health 
and Nutrition Examination Survey”). This difference in sample size may have led to the 
discrepancy in the prevalence of CVD within the NH white population. Regardless, my analysis 
yielded results similar to those published by the CDC, which also used the 2018 NHIS 
(Villarroel et al., Table A-1, 2019). My analysis adds to the CDC report by showing that the 
Hispanic population consistently has a lower prevalence of CVD than the NH white and NH 
black populations after controlling income and education level.    
 
Accounting for a Major CVD Risk Factor: Populations with Diabetes 
The data show that the Hispanic population with diabetes still has a lower prevalence of 
CVD than the NH white and NH black populations with diabetes, but to a lesser extent than in 
the general population. The degree to which the prevalence of CVD within each racial/ethnic 
group differs is reduced. In the general population, the prevalence of CVD amongst Hispanic 
individuals is half that of NH white individuals. However, in the population with diabetes, the 
prevalence of CVD amongst Hispanic individuals is two-thirds that of NH white individuals. 
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This difference is still statistically significant. These data indicate that even after controlling for 
diabetes, a major CVD risk factor, the Hispanic population still has a lower prevalence of CVD 
than the NH white population. Given that both Hispanic individuals with diabetes and NH white 
individuals with diabetes are at risk for CVD, it is startling that proportionally, one-third more 
NH white individuals are diagnosed with CVD. This suggests that perhaps the Hispanic 
population is in some way protected from CVD. 
Comparing the Hispanic population with diabetes to the NH black population with 
diabetes also suggests that Hispanic individuals are in some way protected from CVD. Only 
24.30% of the Hispanic population with diabetes has CVD, compared to 30.24% of the NH black 
population. This difference, however, is not statistically significant. It is interesting that the 
difference in CVD prevalence between the Hispanic population and the NH white/NH 
populations is smaller among populations with diabetes compared to the general population. A 
possible explanation for the narrowing of this disparity relates to the likelihood of visiting health 
care professionals. Individuals who self-identified as having diabetes had necessarily visited a 
health care professional at some point in their lives, as they were asked the question: “Have you 
ever been told by a doctor or health professional that you have diabetes or sugar diabetes?” 
Perhaps Hispanic individuals with diabetes were more likely to continue to go to the doctor and 
therefore more likely to receive a subsequent diagnosis of CVD than Hispanic individuals in the 
general population. According to the 2010 U.S. Census, Hispanic individuals were less likely to 
go the doctor than NH white and NH black individuals. 42.3% of the Hispanic population 
reported not visiting a medical provider in the past year, compared to 22.8% of the NH white 
population and 29.7% of the NH black population (Brett O’Hara & Caswell, 2012). This 
explanation would support the argument that the HHP is a function of data bias—that is, the 
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prevalence of CVD within the Hispanic population is artificially low due to the fact that many 
Hispanic individuals do not go to the doctor.  
 
Accounting for Region of Birth 
The prevalence of CVD is lower in the Hispanic population than the NH white population 
in both the U.S.-born and foreign-born populations. In fact, the difference between the two 
groups stays about the same—the prevalence of CVD in the white population is about twice as 
much as the Hispanic population in both the U.S.-born and foreign-born populations (Figure 7). 
The fact that the prevalence of CVD amongst foreign-born individuals is lower than U.S.-born 
individuals suggests that American culture plays a large role in increasing susceptibility to CVD. 
This is unsurprising, given that the United States is one of the fattest countries in the world 
(Central Intelligence Agency, 2016). The data support the healthy migrant hypothesis, as it is 
shown that the prevalence of CVD is lower among foreign-born members than U.S.-born 
members of each racial/ethnic group. However, the data also indicate that the healthy migrant 
effect alone does not account for the HHP. If this were the case, then we would expect to see 
similar CVD prevalence amongst all foreign-born racial/ethnic groups. However, the data show 
that foreign-born Hispanic individuals still have a lower prevalence of CVD than NH white 
individuals. This is true after controlling for age, although the differences between the two 
populations are no longer statistically significant in individual age classes (likely due to small 
sample size). The fact that the foreign-born Hispanic population has a lower prevalence of CVD 
than the foreign-born NH white population suggests that the Hispanic population has some 




The data support the existence of the Hispanic health paradox by showing that the 
Hispanic population has a lower prevalence of CVD than the NH white and NH black 
populations after controlling for age, income and education level. The data also show that the 
HHP is present in populations with diabetes, as the Hispanic population with diabetes has a 
lower prevalence of CVD than both the NH white and NH black populations with diabetes, but 
to a lesser degree than in the general population. However, this finding also suggests that the low 
prevalence of CVD in the Hispanic population could be due, in part, to under reporting of CVD 
amongst Hispanic individuals as a result of lower rates of doctor visitation. Finally, the data also 
show that the healthy migrant effect likely contributes to the low prevalence of CVD amongst 














CHAPTER V: CONCLUSION 
The data in this thesis show that the Hispanic health paradox (with respect to CVD) is a 
true phenomenon, but that it is likely exaggerated by under reporting of conditions within the 
Hispanic population. Consistent with studies from the American Heart Association and Centers 
for Disease control, the data showed that the Hispanic population in the United States does have 
a lower prevalence of CVD than the NH white and NH black populations. This remains true even 
after controlling for age, income, and education level. The HHP also holds true amongst 
populations with diabetes. The Hispanic population with diabetes also has a lower prevalence of 
CVD than the NH white and NH black populations, indicating that the Hispanic population has a 
health advantage over the other two. However, the differences between racial/ethnic populations 
with diabetes are smaller than those within the general population. In the general population, the 
prevalence of CVD in the Hispanic population is about half as small as the NH white population, 
whereas the prevalence of CVD in the Hispanic population with diabetes is only about one-third 
smaller than the NH white population with diabetes. The fact that the proportion of Hispanic 
individuals with CVD increases with respect to NH white individuals with CVD in the 
population with diabetes could reflect the frequency with which these two groups visit health 
care professionals. Within the general population, Hispanic individuals are less likely to go to the 
doctor than NH white individuals (O’Hara & Caswell, 2012). Within the population with 
diabetes surveyed in the NHIS, all respondents must have visited a doctor at least once to receive 
their diabetes diagnosis. Thus, it can be inferred that in the NHIS, the population with diabetes is 
more likely to go to the doctor than the general population. Perhaps the inflation of CVD rates 
within the Hispanic population with diabetes is due not only to an increased incidence of CVD, 
but also to increased detection of CVD. Given that the prevalence of CVD within the Hispanic 
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population with diabetes increases with respect to the NH white population with diabetes, it is 
likely that in the general population, the detection of CVD was lower in the Hispanic population 
than in the NH white population. This would lend support to the hypothesis that the observation 
of HHP is exaggerated by under reporting of conditions within the Hispanic population. 
Additionally, the data support the existence of the HHP by showing that the low CVD 
prevalence amongst Hispanic individuals is not limited to those born in the United States. 
Though the healthy migrant hypothesis—which suggests that the advantageous health outcomes 
of Hispanic individuals in the United States is due to the selection of healthy immigrants—may 
still be true, it alone does not account for the HHP. Healthy immigrant selection likely plays 
some role, as the data show that foreign-born individuals have a lower prevalence of CVD 
amongst every racial/ethnic group compared to U.S.-born individuals. Because the Hispanic 
population has a high proportion of immigrants, it is likely that healthy immigrant selection has 
some effect on lowering the prevalence of CVD in this population (Flores, 2017). However, 
healthy immigrant selection alone does not account for the HHP. The data show that the foreign-
born Hispanic population still has a lower prevalence of CVD than the foreign-born NH white 
population. This suggests that the Hispanic population has a health advantage over the NH white 
population, regardless of the relative proportion of immigrants in each population (as both these 
populations are completely composed of immigrants). Thus, the HHP cannot be explained 
merely by the high proportion of immigrants within the Hispanic population. The data indicate 
that the Hispanic population has some protective factor against CVD that needs to be further 
explored.   
In conclusion, the data confirm the presence of the Hispanic health paradox within the 
context of CVD by showing that the Hispanic population in the United States has a lower 
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prevalence of CVD than the NH white and NH black populations. The data also show that the 
Hispanic population with diabetes still has a lower prevalence of CVD than the NH white and 
NH black populations, showing that the HHP is present among populations with diabetes. 
However, the differences between these populations are reduced, shedding light on the fact that 
the even-lower prevalence of CVD amongst Hispanics in the general population may be due to 
under-detection. Finally, the data show that both the U.S.-born and foreign-born Hispanic 
populations have a lower prevalence of CVD than the corresponding NH white populations, 
showing that the HHP is still present after controlling for region of birth. This finding indicates 
that the existence of the HHP is not due solely to the increased proportion of immigrants within 
the Hispanic population in the U.S., but that the Hispanic population is somehow protected from 
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Figure 1: Breakdown of Education Level by Race/Ethnicity, 2018 
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